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ABSTRACT 
The present study aims to formulate bilayered tablets of famotidine hydrochloride with a fast release layer using sodium starch 
glycolate, cross povidone and a sustaining floating layer using polymers like HPMC K100M and HPMC K15M by effervescent 
approach. The release characteristics were studied on the basis of gel forming polymer, methocel with different concentration of 
citric acid and sodium bicarbonate. The in vitro buoyancy and floatability were found to be optimum in combination of sodium 
bicarbonate, citric acid and methocel at concentration of 13 mg, 6 mg and 90 mg respectively. The drug release from floating tablets 
was found to be 93.87% for F1 with methocel K15M. The drug release was sustained for a period of 20-24 hours. When compared 
different grades of methocel (K100M and K15M), the methocel K15M (low viscosity grade) provided better-sustained release 
characteristics with excellent in vitro buoyancy. The IR study reveals that there is no any possible interaction between drug and 
excipients used for such formulation. The data from release studies were fitted in different models viz. zero order, first order and 
Korsemeyer’s equation. The result indicated the coupling of swelling and diffusion mechanism so called as Fickian diffusion of 
famotidine from floating tablets. 
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INTRODUCTION 
Development of oral controlled-release systems has been 
a challenge to formulation scientists because of their 
inability to restrain and localize the system in the 
targeted area of the gastrointestinal tract. 
Controlled/sustained release preparations using 
alternative routes have been formulated but the oral 
route still remains preferable. When the drug is 
formulated with a gel forming polymer such as semi-
synthetic derivatives of cellulose, it swells in the gastric 
fluid with a bulk density less than one. It then remains 
buoyant and floats in the gastric fluid, affecting a 
prolonged gastric residence time (GRT).This floating 
dosage form is well known as a hydrodynamically 
balanced system (HBS). 
1–3 
It has been suggested for the 
following instances that an active material should be 
formulated in the form of an HBS to enhance 
bioavailability: (i) having a dissolution and/or stability 
problem in the small intestine fluids, (ii) being locally 
effective in the stomach, (iii) being absorbed only in the 
stomach and/or upper part of the intestine. 
4
 Floating 
tablets, capsules, beads, microspheres and chambers 
have been reported in literature. 
Famotidine is histamineH2 -receptor antagonist. It is 
widely prescribed in gastric ulcers, duodenal ulcers, 
Zollin- ger-Ellison syndrome and gastroesophageal 
reflux disease. The low bioavailability (40-45%) and 
short biological half- life (2.5-4.0 hours) of famotidine 
following oral administration favors development of a 
sustained release formulation. The gastroretentive drug 
delivery systems can be retained in the stomach and 
assist in improving the oral sustained delivery of drugs 
that have an absorption window in a particular region of 
the gastrointestinal tract. These systems help in 
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continuously releasing the drug before it reaches the 
absorption window, thus ensuring optimal 
bioavailability.
6 
It has been reported that the oral 
treatment of gastric disorders with an H2 receptor 
antagonist like famotidine or ranitidine used in 
combination with antacids promotes local delivery of 
these drugs to the receptor of parietal cell wall. Local 
delivery also increases the stomach wall receptor site 
bioavailability and increases efficacy of drugs to reduce 
acid secretion. Hence this principle may be applied for 
improving systemic as well as local delivery of 
famotidine, which would efficiently reduce gastric acid 
secretion.
7
 
Researchers have developed a single layer floating tablet 
of famotidine (JAIMINI N TANWAR). In comparison 
with the single layer tablet, a double layer matrix offers 
advantages; this formulation of the matrix dosage form 
with two distinct layers allows separate regulation of 
drug release kinetics and the floating capabilities to the 
sustained release second layer.
 5
 
The multilayered tablet concept has been long utilized to 
develop sustained release formulations. Such a tablet has 
a fast releasing layer and may contain bi- or triple layers 
to sustain the drug release.
4
 The pharmacokinetic 
advantage relies on the fact that drug release from fast 
releasing granules leads to a sudden rise in the blood 
concentration. However, the blood level is maintained at 
steady state as the drug is released from the sustaining 
granules. 
The present study aims at formulating bilayered tablets 
of famotidine hydrochloride with a fast release layer 
using sodium starch glycolate, cross povidone and a 
sustaining floating layer using polymers like HPMC 
K100M and HPMC K15M by effervescent approach. 
The effect of gel-forming polymer methocel on floating 
properties and release characteristics of famotidine 
tablets were also evaluated. 
MATERIALS AND METHODS  
Materials  
Famotidine was received as a gift sample from Aristo 
Pharmaceuticals Ltd, Bhopal, India. Methocel K100M 
(100 cPs apparent viscosity as a 2% solution) and 
Methocel K15M (15,000 cPs apparent viscosity as a 2% 
solution) were received as gift samples from Colorcon 
Asia Pvt. Ltd., Goa, India. Magnesium stearate, 
Hydrochloric acid, Sodium bicarbonate and Citric acid 
anhydrous were purchased from S.D. Fine Chem Ltd, 
Ahmedabad, India. Polyvinyl pyrrolidone K-30 (PVP K-
30) was procured from Ottokemi, Mumbai, India. 
Lactose and purified Talc were purchased from E. 
Merck (India) Ltd., Mumbai. All other ingredients were 
of laboratory grade. 
Preparation and characterization of bilayer tablets 
The bilayer tablets of famotidine hydrochloride were 
prepared by the wet granulation method. The drug and 
polymers for both fast release and sustaining layer were 
passed through a respective sieve before their use in the 
formulation. 
 
Formulation of the fast release layer– 
The dose in the formulation for fast release was 10 mg, 
the maintenance dose or sustained dose (30 mg) of 
famotidine hydrochloride. The granules were prepared 
by kneading the intragranular disintegrating agent and 
excipients and adding water as a binder. Granules 
screened with an 18 mesh sieve were dried and mixed 
with excipients. Disintegrating agent could also be 
added to the granules as extra granular disintegrates, and 
then mixed with talc and magnesium stearate. The 
blends was compressed into tablets using flat punch of 
diameter 8.00 mm Remiek 12 station mini press tablet 
machine. 
Formulation of the sustained release layer –  
The entire ingredient were weighed accurately and 
mixed thoroughly. Granulation was done with a solution 
of PVP K 30 in sufficient alcohol. Granules then passed 
through sieve (mesh 40) were dried in conventional hot 
air oven at 45 °C. Drying of the granules was stopped 
after proper drying. Then dried granules were sized from 
mesh 40/60 and lubricated with purified talc and 
magnesium stearate. The blend was compressed into 
tablet flat punch of diameter 8.00 mm Remiek 12 station 
mini press tablet machine. 
 
Characterization of granules: 
 Prior to compression, granules were evaluated for their 
characteristic parameters, such as tapped density, Carr’s 
index and angle of repose.
8 Carr’s compressibility index 
was calculated from the bulk and tapped densities
 8
 using 
a digital tap density apparatus (Electrolab Ltd, India). 
Compression of bilayer tablet–The quantity of 
granules for the sustained release layer was compressed 
lightly using a single punch tableting machine (Remiek 
12 station mini press tablet machine) equipped with 8 
mm round, flat punches. Over this compressed layer, the 
required quantity of the fast release layer was placed and 
compressed to obtain hardness in the range of 4-5 kg 
cm
–2
 to form a bilayer floating tablet. 
Physical tests for the bilayer tablets –Standard 
physical tests for the bilayer matrix tablets were 
performed (16) and average values were calculated. 
Mass variation was determined by weighing 20 tablets 
individually, the average mass was calculated and the 
percent variation of each tablet was calculated. Hardness 
was determined by taking 6 tablets from each 
formulation using a Monsanto hardness tester 
(Electrolab Pvt. Ltd., India) and the average of pressure 
(kg cm
–2
) applied for crushing the tablet was determined. 
Friability was determined by first weighing 10 tablets 
after dusting and placing them in a friability tester 
(Electrolab Pvt. Ltd., India), which was rotated for 4 min 
at 25 rpm. After dusting, the total remaining mass of the 
tablets was recorded and the percent friability was 
calculated. 
In vitro buoyancy studies 
The in vitro buoyancy was determined by floating lag 
times according to the method described by Rosa et al. 
9
. 
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The tablets were placed in a 100-mL beaker containing 
0.1mol L
–1
HCl. The time required for the tablet to rise to 
the surface and float was taken as the floating lag time. 
The experiments were conducted in triplicate. 
Drug content uniformity– Twenty tablets were 
weighed and finely powdered and powder equivalent to 
average weight was added in 100-mL of 0.1 N 
hydrochloric acid, followed by stirring for 30 minutes, 
the solution was filtered and diluted suitably and the 
absorbance of resultant solution was measured 
spectrophotometrically at 266 nm using 0.1 N HCl as 
blank. 
In-vitro Dissolution study 
The release rate of famotidine from immediate release 
tablets was determined using United State 
Pharmacopoeia (USP) XXIV dissolution testing 
apparatus II (paddle method). The dissolution test was 
performed using 900 ml of 0.1 N HCl (pH=1.2), at 37 
±0.5°C and 50 rpm. A sample (5 ml) of the solution was 
withdrawn from the dissolution apparatus at an interval 
of 0.5,1,2,4,8,12,16,20,22,24 hours and the samples 
were replaced with fresh dissolution medium of same 
quantity. The samples were filtered through a filter. 
Absorbances of these solutions were measured at 266 
nm.  
Kinetic analysis of dissolution data 
The rate and mechanism of release of propranolol 
hydrochloride from the prepared bilayer tablets were 
analyzed by fitting the dissolution data into the zero-
order equation 
10
: 
Q = k0t 
Where Q is the amount of drug released at time t , and 
kis the release rate constant, fit - ted to the first order 
equation (19): 
ln (100–Q) = ln 100 – k1t 
Where k1is the release rate constant. The dissolution data 
was fitted to the Higuchi’s equation 12 
Q = k2t
1/2
 
Where k2is the diffusion rate constant. 
The dissolution data was also fitted to the well known 
equation (Korsmeyer equation), which is often used to 
describe the drug release behavior from polymeric 
systems 
13
: 
log (Mt/ M∞) = log k + n log t 
Where Mt is the amount of drug released at time t, M∞ is 
the amount of drug release after infinite time, k is a 
release rate constant incorporating structural and 
geometric characteristics of the tablet and n is the 
diffusional exponent indicative of the mechanism of 
drug release. 
FT-IR study 
Infrared spectrum was taken (FT-IR, Spectrum RX 1, 
Perkin Elmer Ltd, Switzerland) by scanning the sample 
in potassium bromide discs. The samples of pure drug 
and granules containing different polymers were 
scanned individually. 
 
Figure 1: IR Spectra of famotidine and HPMC K100M 
RESULTS AND DISCUSSION 
Flow Properties of Granules  
The granules prepared for compression of bilayer 
floating tablets were evaluated for their flow properties 
(Table 2). Angle of repose was in the range of 31.23 to 
34.02 with granules containing methocel K100M and 
32.16 with methocel K15M. Bulk density ranged 
between 0.46 to 0.57gm/cm
3
 with granules containing 
methocel K100M and 0.46gm/cm
3
 with methocel 
K15M. Tapped density ranged between 0.54 to 
0.68gm/cm
3
 with granules containing methocel K100M 
and 0.53gm/cm
3
 with methocel K15M. Hausner’s ratio 
ranged from 1.1 to 1.2 for granules of different 
formulations. These values indicate that the prepared 
granules exhibited good flow properties. 
 
Table 1: Optimization of fast release layer 
        BATCH CODE 
INGREDIENT* A1 A2 A3 A4 A5 A6 
FAMOTIDINE 10 10 10 10 10 10 
POVIDONE 2 3 4 - - - 
SSG - - - 2 4 6 
DCP 85 84 83 85 83 81 
TALC 2 2 2 2 2 2 
MG STEATARTE 1 1 1 1 1 1 
TOTAL 100 100 100 100 100 100 
*All the ingredient in mg 
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Table 2: Optimization of Sustained release layer 
                    Batch code 
Ingredients* 
F1 F2 F3 F4 F5 F6 F7 F8 
Famotidine 30 30 30 30 30 30 30 30 
HPMC K 15 M 40 - - - - - - - 
HPMC K 100 M - 40 30 60 50 40 40 40 
Sodium bi carbonate 12 12 12 12 12 13 13 13 
Citric acid 6 6 6 6 6 6 5 3.75 
Lactose 20 20 20 20 20 24 24 24 
Talc 1 1 1 1 1 1 1 1 
Magnesium stearate 1 1 1 1 1 1 1 1 
Floating lag time 
(Seconds) 
42 44 39 60 51 44 52 70 
*All the ingredient are in mg 
 
Table 3:  Characterization of powder of floating layer 
                        Batch code 
Parameters F1 F2 F3 F4 F5 F6 F7 F8 
Bulk density (g/cc) 0.46 0.46 0.47 0.57 0.48 0.54 0.51 0.47 
Tapped density (g/cc) 0.53 0.54 0.55 0.68 0.58 0.65 0.61 0.56 
Compressibility index (%) 13.20 14.81 14.5 16.1 17.2 16.9 16.3 19.1 
Hausner ratio 1.15 1.17 1.17 1.19 1.2 1.2 1.1 1.19 
Angle of repose (ø) 32.16 34.02 33.34 33.21 33.56 32.75 33.03 31.23 
% Weight variation 4.5 4.7 4.7 4.4 4.8 4.8 4.5 4.6 
% Friability 0.11 0.13 0.12 0.11 0.12 0.11 0.12 0.12 
% Drug content 98.55 98.74 99.05 98.66 98.80 98.52 99.12 98.76 
 
FT-IR study 
The FT-IR spectrum of famotidine hydrochloride and 
HPMC K100M, shown in Fig. 1, revealed the presence 
of peaks at 3399.89 cm 
–1
 due to the asymmetrical N-H 
stretching, peaks at 1658.48 cm 
–1
due to the C=C 
stretching, symmetrical N-H stretching band at 3376.75 
cm 
–1
 and the peak at 1638.00 cm
–1
 was due to a C=N 
stretching. Major frequencies of functional groups of 
pure drug remain intact in granules containing polymers; 
hence, there is no major interaction between the drug 
and polymers used in the study.  
Evaluation of Floating Tablets  
The bilayer floating tablets of famotidine were prepared 
by effervescent technique using methocel (K100M, 
K15M), sodium bicarbonate, citric acid and PVP K-30. 
The magnesium stearate and talc were used as lubricant 
and glidant, respectively. The results of the 
physicochemical characterization are shown in Table 3. 
The weight of the tablet varied between 200 mg to 230 
mg for different formulations with low standard 
deviation values, indicating uniformity of weight. The 
variation in weight was within the range of ±5% 
complying with pharmacopoeial specifications.
 5 
The 
hardness for different formulations was found to be 
between 4.05 to 5.25 kg/cm 2 indicating satisfactory 
mechanical strength. The friability was below 1% for all 
the formulations, which is an indication of good 
mechanical resistance of the tablet. The drug content 
varied between 39.26 to 39.92 mg in different 
formulations with low coefficient of variation (C.V. < 
1.0%), indicating content uniformity in the prepared 
batches. All the tablets were prepared by effervescent 
approach. Sodium bicarbonate was added as a gas-
generating agent. Sodium bicarbonate induced carbon 
dioxide generation in presence of dissolution medium 
(0.1 N hydrochloric acid). 
The combination of sodium bicarbonate and citric acid 
provided desired floating ability and therefore this 
combination was selected for the formulation of the 
floating tablets. It was observed that the gas generated is 
trapped and protected within the gel, formed by 
hydration of polymer (methocel), thus decreasing the 
density of the tablet below 1 and tablet becomes 
buoyant. The tablet swelled radially and axially during 
in vitro buoyancy studies. The concentration of gas-
generating agent affected the floating lag time, as the 
amount of gas-generating agent was increased, the 
floating lag time decreased. The incorporation of gas-
generating agent exhibits reduction the in floating lag 
time. Due to high solubility of drug there was no effect 
observed on release pattern. 
All the batches of tablets were found to exhibit short 
floating lag times due to presence of sodium bicarbonate 
and citric acid. Decrease in the citric acid level increased 
the floating lag time and tablets were found to float for 
longer duration. The tablets with low-viscosity grade 
methocel K15M or low concentration of polymer 
exhibited short floating lag time and floated for longer 
duration as compared with formulations containing 
high-viscosity grade methocel K100M or high 
concentration of polymer. This indicated that the 
molecular weight distribution or viscosity of the gel-
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forming polymer methocel influenced the in vitro 
buoyancy.  
Reduction in methocel level in the formulations F4, F5, 
and F9, F10 prolonged the floating lag time and 
shortened the total floating time. Thus a combination of 
sodium bicarbonate (13mg) and citric acid (6mg) with 
methocel (90mg) was found to achieve optimum in vitro 
buoyancy and floatability.   
The pH of the stomach is elevated under fed condition 
(~3.5), therefore citric acid was incorporated in the 
formulation to provide an acidic medium for sodium 
bicarbonate; more over citric acid has an stabilizing 
effect on famotidine formulation. The effect of methocel 
in the tablet with varying proportion of citric acid and 
sodium bicarbonate was studied on the release 
characteristics.   
It is evident from the in vitro dissolution data that 
increase in citric acid concentration increased the release 
rate but reduced the floating time, probably due to of 
excess carbon dioxide, disturbing the monolithic tablet. 
The citric acid level in the formulations greatly 
influenced the drug release, irrespective of methocel 
grade.  
The drug release from floating tablets was found to be 
93.87% for F1 with methocel K15M. The drug release 
for formulations containing high-viscosity grade 
methocel K100M (F2 to F8) varied between 84.41 to 
94.83%.  
The prepared formulations sustained the drug release for 
a period of 20-24 hours. Comparing the two different 
grades of methocel (K100M and K15M), it was found 
that low-viscosity grade methocel K15M provided 
better-sustained release characteristics with excellent in 
vitro buoyancy. Formulations containing sodium 
bicarbonate and citric acid in ratio of 13:1 with varying 
amount of methocel were studied for their effect on 
release profile of famotidine. It was observed that the 
release of famotidine from such formulations increased 
on decreasing the proportion of methocel in the 
formulation but duration of floating decreased. 
The data obtained from in vitro dissolution studies were 
fitted in different models viz. zero order, first order and 
Korsemeyer’s equation (Table 4). As clearly indicated in 
table 4, the correlation coefficient value of all the 
formulations showed that the formulations did not 
follow zero order release pattern but batch F2 and F6 
shows fair zero order. When the data were plotted 
according to the first order equation, the formulations 
show a fair linearity, with correlation coefficient values 
between 0.9509-0.9848. To explore the release pattern, 
results of the in-vitro dissolution data were fitted to the 
Korsmeyer equation, which characterizes the transport 
mechanism. Regression analysis was performed and 
regression values ‘r2’ were0.9038to 0.9915 for different 
formulations. Slope values (0.5<n<1.0) of 0.37indicates 
the coupling of swelling and diffusion mechanism so 
called as Fickian diffusion of famotidine from floating 
tablets.
 
Table 4: Kinetic treatment of dissolution data of famotidine hydrochloride 
Formulation code 
 
Correlation coefficient (r
2
) Peppas release                                                                                                                 
exponent (n ) Zero order First order Higuchi’s type 
F1 0.8518 0.9848  0.9492  0.9459 
F2 0.957 0.9591 0.9855  0.8619 
F3 0.9129 0.8159  0.9038  0.9399 
F4 0.9105  0.9653 0.9823  0.9635 
F5 0.8815 0.9842 0.9672 0.9313 
F6 0.9498 0.9509 0.9915  0.9945 
F7 0.8365 0.9813 0.9769  0.9895 
F8 0.8285 0.9757 0.974  0.9909 
 
 
Figure 2: Kinetic analysis of dissolution data 
(Korsmeyer equation) 
 
Figure 3: Kinetic analysis of dissolution data (Higuchi 
Plot) 
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Figure 4: Kinetic analysis of dissolution data (First order 
Release) 
 
CONCLUSION  
Oral solid dosage form based on bilayer floating drug 
delivery is promising to achieve bimodal drug release. 
After an immediate drug release from first layer, 
controlled release can be achieved from second layer in 
an area that could maximize drug reaching its absorption 
site. The addition of gel-forming polymer methocel 
(K100M and K15M) and gas-generating agent sodium 
bicarbonate along with citric acid was essential to 
achieve in vitro buoyancy. The drug release from the 
tablets was sufficiently sustained and Fickian transport 
of the drug from tablets was confirmed. 
This system can be useful for pharmaceuticals following 
chronopharmacology and having limited physiological 
stability and absorption window in upper part of GI 
tract. However, further clinical studies are needed to 
explore potential of system for antibiotics. 
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